Low plasma CC16 levels in smokers are associated with a higher risk for chronic bronchitis

Petersen Hans, Leng Shuguang, Belinsky Steven A., Miller Bruce E., Tal-Singer Ruth, Owen Caroline A., Celli Bartolome, Tesfaigzi Yohannes

Source: Eur Respir J 2015; 46: 1501-1503
Journal Issue: November
Disease area: Airway diseases

Full text journal articlePDF journal article, handout or slides

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
Petersen Hans, Leng Shuguang, Belinsky Steven A., Miller Bruce E., Tal-Singer Ruth, Owen Caroline A., Celli Bartolome, Tesfaigzi Yohannes. Low plasma CC16 levels in smokers are associated with a higher risk for chronic bronchitis. Eur Respir J 2015; 46: 1501-1503

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
HDL serum levels are significantly lower in patients with COPD than in never-smokers
Source: International Congress 2017 – COPD: from screening to risk factors of lung cancer
Year: 2017

Cigarette smoking induced elevated CXCL5 levels in BALF and plasma of patients with COPD
Source: International Congress 2018 – COPD: novel pathological mechanisms in the airway epithelium
Year: 2018

Elevated circulating MMP-9 is associated with increased exacerbation risk in COPD: results from SPIROMICS and COPDGene
Source: International Congress 2018 – How far are we in terms of predicting mortality and exacerbations in COPD?
Year: 2018



Elevated hsCRP is associated with respiratory symptoms in COPD
Source: International Congress 2019 – More and more COPD
Year: 2019

Leptin levels in induced sputum from patients with COPD are sensitive to smoking status
Source: Eur Respir J 2005; 26: Suppl. 49, 660s
Year: 2005

Characterisation of asthma subgroups associated with circulating YKL-40 levels
Source: Eur Respir J, 50 (4) 1700800; 10.1183/13993003.00800-2017
Year: 2017



Increased serum endotoxin levels as biomarker in acute exacerbations of COPD.
Source: International Congress 2018 – Biomarkers of COPD
Year: 2018

Inflammation-sensitive plasma proteins are associated with increased incidence of COPD
Source: Eur Respir J 2007; 30: Suppl. 51, 629s
Year: 2007

Plasma surfactant protein A levels are increased in smokers but do not correlate with respiratory symptoms and airway obstruction
Source: Annual Congress 2010 - COPD: phenotyping and monitoring
Year: 2010

Late Breaking Abstract - Increased serum levels of YKL-40 in male smoking chronic obstructive pulmonary disease patients associated with altered miRNA levels in alveolar macrophages
Source: Virtual Congress 2020 – New biomarkers for management of obstructive diseases
Year: 2020




Are C-reactive protein levels associated with bacteria in COPD exacerbations?
Source: Eur Respir J 2015; 45: 1515-1516
Year: 2015


Are C-reactive protein levels associated with bacteria in COPD exacerbations?
Source: Eur Respir J 2015; 45: 1514-1515
Year: 2015


Serum interleukin-6 levels correlate with malnutrition in patients with acute exacerbation of COPD
Source: Annual Congress 2009 - Organisation of care for individuals with chronic respiratory disease
Year: 2009


Potential association between cigarette smoking and IL-18 levels in induced sputum of healthy and asthma smokers
Source: Eur Respir J 2007; 30: Suppl. 51, 363s
Year: 2007

Increased plasma fibrinogen could predict frequent exacerbations in asthma
Source: Virtual Congress 2020 – Prediction of outcomes in obstructive diseases
Year: 2020


Cigarette smoking acutely decreases the serum levels of the COPD biomarker sRAGE
Source: International Congress 2018 – Novel findings in biomarkers of tobacco use, exposure, hazards and genetics
Year: 2018



Effect of smoking cessation on sputum HNP levels in COPD patients and asymptomatic smokers
Source: Annual Congress 2008 - Towards smoking cessation
Year: 2008


Overexpression of chitotriosidase and YKL-40 in serum and sputum in healthy smokers and patients with  chronic obstructive pulmonary disease
Source: International Congress 2018 – Clinical determinants and biomarkers of COPD
Year: 2018




Serum levels of IL-6 in adult patients with moderate to severe asthma.
Source: International Congress 2017 – Novel mechanisms in asthma
Year: 2017


Increased serum α1-antitrypsin level in COPD patients with predominant lung emphysema
Source: Eur Respir J 2001; 18: Suppl. 33, 248s
Year: 2001